Physician profile

Paul S Han

Pulmonary Disease · Englewood, NJ

NPI 1174590558

$26,874.54

in general payments reported to CMS, 2019-2025

64 companies · $5,199 in 2025

The $5,199 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$11,425.31
Education$1,893.11
Travel and Lodging$1,636.09

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $3,501.54 2019-2025 Fasenra, Tezspire, Airsupra
Glaxosmithkline, LLC. $2,507.89 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Intuitive Surgical, INC. $2,132.86 2024
Boehringer Ingelheim Pharmaceuticals, INC. $1,814.94 2019-2025 Ofev, Jascayd, Spiriva Respimat
Genentech USA, INC. $1,701.48 2019-2022
Noah Medical Corporation $1,345.73 2024-2025 Galaxy
Philips North America LLC $1,224.32 2019-2025 (Ak6) Vest Therapy, Vest Therapy Und
Genzyme Corporation $1,067.58 2019-2025
Regeneron Healthcare Solutions, INC. $962.38 2019-2025 Dupixent
Insmed, INC. $933.73 2019-2025 Arikayce, Brinsupri
Inspire Medical Systems, INC. $908.36 2023-2025 Inspire
Hill-Rom Company, INC $875.00 2021
Jazz Pharmaceuticals INC. $758.07 2020-2025
Amgen INC. $664.87 2021-2025 Otezla, Tezspire, Krystexxa
Avadel Cns Pharmaceuticals, LLC $610.32 2023-2025 Lumryz
Show all 64 companies
CompanyGeneral paymentsYearsTop products
Mylan Specialty L.P. $571.21 2019-2024 Yupelri
Abbvie INC. $434.11 2021-2025
Harmony Biosciences LLC $418.74 2020-2024 Wakix
Allergan, INC. $347.17 2019-2020
Electromed, INC. $338.56 2021-2025 Smartvest
Grifols USA, LLC $295.98 2019-2025 Prolastin-C Liquid, Xembify
Merck Sharp & Dohme LLC $275.62 2019-2025 Belsomra, Keytruda, Verquvo
Sanofi-Aventis U.S. LLC $241.74 2023-2025
Viatris Specialty LLC $191.87 2025 Yupelri
Takeda Pharmaceuticals U.S.A., INC. $191.08 2020-2025 Glassia
Axsome Therapeutics, INC. $185.37 2023-2025 Sunosi
Teva Pharmaceuticals USA, INC. $183.87 2019-2022
Aerin Medical INC. $177.16 2025
Galvanize Therapeutics, INC $177.03 2024 Aliya System
United Therapeutics Corporation $165.31 2021-2025 Tyvaso, Tyvaso
Vifor Pharma, INC. $161.87 2024-2025 Zemaira
Janssen Pharmaceuticals, INC $146.61 2019-2022
Inari Medical, INC. $137.01 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Baxter Healthcare $136.01 2022-2023 Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care
Sunovion Pharmaceuticals INC. $127.53 2019
Pfizer INC. $75.66 2019-2025
Mallinckrodt Hospital Products INC. $74.29 2022-2023 Acthar
Novartis Pharmaceuticals Corporation $63.58 2019-2020
Azurity Pharmaceuticals, INC. $61.22 2023-2025 Horizant, Alvesco, Horizant
Advanced Respiratory, INC $57.06 2021
Verona Pharma, INC. $53.96 2025 Ohtuvayre
Novo Nordisk INC $49.35 2023 Wegovy
Idorsia Pharmaceuticals US INC $47.59 2023 Quviviq
Gilead Sciences, INC. $42.98 2022
Mallinckrodt Enterprises LLC $38.66 2019
Lilly USA, LLC $38.21 2025 Zepbound
Optinose US, INC. $33.10 2023-2025
Alexion Pharmaceuticals, INC. $32.45 2023 Ultomiris
Covis Pharma Gmbh $31.35 2022
Eisai INC. $29.43 2021
Amarin Pharma, INC. $28.99 2021
Arbor Pharmaceuticals, INC. $26.31 2019-2022
Pulmonx Corporation $21.53 2022
Tactile Systems Technology INC $17.78 2025 Nimbl, Flexitouch Plus
Actelion Pharmaceuticals US, INC. $16.42 2023 Opsumit
Resmed Corp $15.76 2020
Inogen, INC. $14.89 2023 Inogen One G5 Oxygen Concentrator - Bluetooth
Covidien LP $14.06 2020
Sanofi Pasteur INC. $14.00 2020
Angiodynamics, INC. $13.26 2021
Circassia INC. $13.23 2020
Aytu Biopharma, INC. $12.93 2019
Itamar Medical INC $12.33 2025 Watchpatone
Nabriva Therapeutics, Plc $11.24 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paul S Han

$26,874.54

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $5,199 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/234787/paul-s-han

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.